• Vétoquinol’s third-quarter 2026 sales rose 10.4% on a reported basis to €139.7 million.
• Quarterly constant-currency sales increased 9.6%, with Essentials sales growing 12.9% on the same basis.
• Sales for the first nine months rose 3.9% on a reported basis to €399 million.
• Nine-month constant-currency growth reached 5.4%, or 6.6% excluding the impact of complementary product-line simplification.
• Essentials generated €259 million in nine-month sales, accounting for 64.9% of total revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vétoquinol SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202610281245BIZWIRE_USPR_____20261028_BW668186) on October 28, 2026, and is solely responsible for the information contained therein.